Zhitong Finance App News, ShapeAce (603168.SH) issued an announcement. Recently, the company received a “Drug Registration Certificate” for compound topicamide eye drops issued by the State Drug Administration. This drug is suitable for dilating pupils and regulating paralysis for the purpose of diagnosis and treatment. The company obtained its “Drug Registration Certificate” this time, which will further enrich the company's product categories and help optimize the company's product layout.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.